Pharmacology of heparin and related drugs: an update
J Hogwood, B Mulloy, R Lever, E Gray, CP Page… - Pharmacological …, 2023 - Elsevier
Heparin has been used extensively as an antithrombotic and anticoagulant for close to 100
years. This anticoagulant activity is attributed mainly to the pentasaccharide sequence …
years. This anticoagulant activity is attributed mainly to the pentasaccharide sequence …
The role of leukocytes in thrombosis
LL Swystun, PC Liaw - Blood, The Journal of the American …, 2016 - ashpublications.org
In recent years, the traditional view of the hemostatic system as being regulated by a
coagulation factor cascade coupled with platelet activation has been increasingly …
coagulation factor cascade coupled with platelet activation has been increasingly …
Vascular occlusion by neutrophil extracellular traps in COVID-19
M Leppkes, J Knopf, E Naschberger, A Lindemann… - …, 2020 - thelancet.com
Background Coronavirus induced disease 2019 (COVID-19) can be complicated by severe
organ damage leading to dysfunction of the lungs and other organs. The processes that …
organ damage leading to dysfunction of the lungs and other organs. The processes that …
Neutrophil extracellular traps and endothelial dysfunction in atherosclerosis and thrombosis
H Qi, S Yang, L Zhang - Frontiers in immunology, 2017 - frontiersin.org
Cardiovascular diseases are a leading cause of mortality and morbidity worldwide.
Neutrophils are a component of the innate immune system which protect against pathogen …
Neutrophils are a component of the innate immune system which protect against pathogen …
Circulating histones in sepsis: potential outcome predictors and therapeutic targets
Y Li, D Wan, X Luo, T Song, Y Wang, Q Yu… - Frontiers in …, 2021 - frontiersin.org
Sepsis is defined as a life-threatening organ dysfunction caused by a dysregulated host
response to infection and is associated with high morbidity and mortality. Circulating …
response to infection and is associated with high morbidity and mortality. Circulating …
The anticoagulant and nonanticoagulant properties of heparin
DMH Beurskens, JP Huckriede… - Thrombosis and …, 2020 - thieme-connect.com
Heparins represent one of the most frequently used pharmacotherapeutics. Discovered
around 1926, routine clinical anticoagulant use of heparin was initiated only after the …
around 1926, routine clinical anticoagulant use of heparin was initiated only after the …
Bleeding related to disturbed fibrinolysis
The components and reactions of the fibrinolysis system are well understood. The pathway
has fewer reactants and interactions than coagulation, but the generation of a complete …
has fewer reactants and interactions than coagulation, but the generation of a complete …
Neutrophil extracellular traps mediate deep vein thrombosis: from mechanism to therapy
M Yao, J Ma, D Wu, C Fang, Z Wang, T Guo… - Frontiers in …, 2023 - frontiersin.org
Deep venous thrombosis (DVT) is a part of venous thromboembolism (VTE) that clinically
manifests as swelling and pain in the lower limbs. The most serious clinical complication of …
manifests as swelling and pain in the lower limbs. The most serious clinical complication of …
Low molecular weight heparins prevent the induction of autophagy of activated neutrophils and the formation of neutrophil extracellular traps
The protection exerted by neutrophils against invading microbes is partially mediated via the
generation of neutrophil extracellular traps (NETs). In sterile conditions NETs are damaging …
generation of neutrophil extracellular traps (NETs). In sterile conditions NETs are damaging …
Neutrophil extracellular traps promote hypercoagulability in patients with sepsis
S Yang, H Qi, K Kan, J Chen, H **e, X Guo, L Zhang - Shock, 2017 - journals.lww.com
Background: Patients with sepsis commonly exhibit a hypercoagulability with high risk of
venous thromboembolism (VTE). Neutrophil extracellular traps (NETs) are found to trigger …
venous thromboembolism (VTE). Neutrophil extracellular traps (NETs) are found to trigger …